Clinical Trial Update: The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating how thyroid hormone affects drug elimination in cancer patients; status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Cancer

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Thyroid Cancer | Phase 2 | Status: COMPLETED